# Synthesis Institute

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/synthesis-institute-b-v

- Industry: Healthcare
- Headquarters: Amsterdam, Netherlands
- Website: www.synthesisretreat.com
- Total disclosed funding: $2.8M
- Latest round: Seed (Jul 7, 2020)
- Investors on record: 1

## About

Synthesis Institute B.V. offers immersive psychedelic retreat experiences centered around the legal use of psilocybin-containing truffles, focusing on personal growth and emotional insight in a supportive environment.Synthesis Institute B.V. specializes in immersive psychedelic retreats. Founded in 2017, the company is headquartered in Amsterdam, Netherlands. The founders, Martijn Schirp and Paul Austin, previously engaged in the wellness sector. In July 2020, Synthesis raised USD 2.75 mn in a Seed funding round led by Novamind Ventures, marking their total funding to the same amount from this round. They have completed one deal.Synthesis Institute B.V. specializes in providing immersive psychedelic retreat experiences that utilize psilocybin-containing truffles legally. Their offerings include a comprehensive three-part program consisting of pre-retreat preparation, a five-day experiential retreat, and post-retreat integration sessions. Participants undergo two psychedelic ceremonies and partake in workshops that translate their insights into actionable outcomes. The company attracts a broad clientele seeking transformation and healing, with retreats primarily held in the Netherlands and Costa Rica, targeting markets in North America and Europe.Synthesis Institute B.V. operates on a tuition-based model with a program priced at USD 5,797 per participant. This fee encompasses all retreat aspects, from preparation sessions to post-retreat integration support. They maintain a direct-to-consumer approach, with clients undergoing health screenings prior to enrollment and opting for payment plans that may include one-time or two-installment options.Following their USD 2.75 mn Seed funding in July 2020, Synthesis Institute B.V. aims to expand its offerings and geographic reach. The funds will support the development of new retreat programs and expansion into additional markets, particularly targeting regions with growing interest in psychedelic therapy by the end of 2023.

## Funding rounds

- Seed, Jul 7, 2020, $2.8M — Novamind Ventures

## Investors

- Novamind Ventures (https://capitalatlas.ai/funds/novamind-ventures) — Seed